1. Redman CWG, Beilin LJ, Bonnar J, Ounsted MK: Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 1976, 2:753–756.
2. Lindheimer MD, Roberts JM, Cunningham FG: Chesley’ Hypertensive Disorders in Pregnancy, edn 2. Stamford: Appleton & Lange; 1999. This 654-page, multiauthored text provides the most comprehensive review available of cardiovascular physiology and pathophysiology in pregnancy, insights to the pathogenesis of pre-eclampsia, and critical review of strategies for the clinical management of these patients.
3. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. NIH Publication No. 00-3029, July 2000. Accessible at www.nhlbi.nih.gov/health/prof/heart/hbp_preg.htm This consensus statement, revised 10 years after its initial publication, provides useful guidelines for the evaluation and management of hypertensive gravidas.
4. Brown MA, Hague WM, Higgins J, et al.: The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N Z J Obstet Gynecol 2000, 40:139–155. This consensus statement of the Australasian Society for the Study of Hypertension in Pregnancy provides useful guidelines with minor specific differences from the NHBPEP Working Group.
5. Rey E, LeLorier J, Burgess E, et al.: Report of the Canadian Hypertension Society consensus conference. 3. Pharmacologic treatment of hypertensive disorders in pregnancy. Can Med Assoc J 1997, 157:1245–1254. The Canadian Hypertension Society statement, based on a critical literature review, preceded publication of references 3 and 4, above. These three sets of clinical guidelines are in essential agreement, reflecting perhaps appropriate circumspection in the face of limited data.